ARD

ARD is owned by Vivescia.

Vivescia has 4 subsidiaries including ARD, Malteurop and SeVeal.

They are in:

• Agriculture60%
• Biotechnology20%
• Other20%

View the org chart displaying its 3 main executives

Most searched biographies at ARD

• Jean Christophe Duval, Chief Executive Officer
• Alain Le Floch, Chairman of the Board
• Boris Estrine, Chemistry Manager

Create your alert
to follow the executive moves at ARD.

Vivescia has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Kristina Burow - Director at Scholar Rock

Learn more about the Biotechnology industry >

Press releases by ARD

Social media about ARD

• ARD on Wikipedia, Google News & Yahoo Finance
• ARD on LinkedIn, Twitter & YouTube

Call ARD at +33 32...

View the org chart

Register to receive your alert

Report an error